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Abstract: This review discusses recent advances in the synthesis, characterization and 
toxicity of metal oxide nanoparticles obtained mainly through biogenic (green) processes. 
The in vitro and in vivo toxicities of these oxides are discussed including a consideration of 
the factors important for safe use of these nanomaterials. The toxicities of different metal 
oxide nanoparticles are compared. The importance of biogenic synthesized metal oxide 
nanoparticles has been increasing in recent years; however, more studies aimed at better 
characterizing the potent toxicity of these nanoparticles are still necessary for nanosafely 
considerations and environmental perspectives. In this context, this review aims to inspire 
new research in the design of green approaches to obtain metal oxide nanoparticles for 
biomedical and technological applications and to highlight the critical need to fully 
investigate the nanotoxicity of these particles.  
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1. Introduction 
Metal oxide nanoparticles have wide applications, primarily in the technology field, including their 
use as a semiconductor, electroluminescent or thermoelectric material, but they are also used in 
biomedical applications as drug delivery systems for treatment and diagnosis and in environmental 
decontamination applications [1,2]. The classical methods for obtaining metal oxide nanoparticles are 
based on chemical and physical techniques that employ hazardous and expensive chemicals with high 
energy input and a negative effect on the environment [1]. The production of metal oxide nanoparticles 
via biogenic synthesis has received increasing attention recently because it is a novel process for the 
development of engineered materials [3]. The biogenic synthesis of nanomaterials by different 
organisms offers a reliable, low-cost and environment friendly alternative approach compared with 
classical chemical and/or physical methods [3–8]. The biogenic synthesis of metallic nanoparticles 
leads to the formation of capped nanostructures with proteins/biomolecules from the organism during 
the biosynthesis. These capping agents prevent nanoparticle aggregation and likely play an important 
role in the stabilization of the nanosystem. The presence of capping agents may improve the 
biocompatibility of biogenic nanomaterials [3–8]. Figure 1 shows a schematic representation of the 
simplicity of biogenic synthesis of metal oxide nanoparticles along with the advantages and 
disadvantages of green processes. 
 
Figure 1. Schematic representation of the biogenic synthesis of metal oxide nanoparticles 
and its advantages and disadvantages.  
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As highlighted in Figure 1, biogenic methods to obtain metal oxide nanoparticles are performed at 
room conditions, in a simple and cost effective manner and with no contamination to the environment. 
However, the main disadvantages are the limitations related to the scaling up the syntheses processes. 
In addition, the reproducibility of the biogenic processes needs to be improved, and in most of the 
cases, the mechanisms of nanoparticle formation are not completely elucidated [3–8].  
The increasing production and use of metal oxide nanoparticles in numerous applications leads to 
adverse effects on health [9]. Several studies have demonstrated nanoparticle toxicity and  
increased cytotoxic potential of these materials [10]. However, a better understanding of the biological 
mechanisms of cytotoxicity and/or genotoxicity is necessary [11]. Silver nanoparticles are  
the most studied metallic nanoparticles but their cytotoxicity and genotoxicity are not fully  
understood [10,12–15]. The toxicity of more complex nanostructures, such as graphene and carbon 
nanotubes, is also uncertain [16]. 
This review describes the biogenic synthesis of important metal oxide nanoparticles and their 
cytotoxicity in vivo and in vitro. The safety implications and environment effects of these nanoparticles 
are also discussed.  
2. Biogenic Synthesis of Metal Oxide Nanoparticles 
This section describes the biogenic routes (green approaches) to synthesize different  
metal oxide nanoparticles. These particles are important for technological, biomedical and 
environmental applications.  
2.1. Bismuth Trioxide (Bi2O3) Nanocrystals 
Bi2O3 nanocrystals are an optoelectronic material. This metal oxide has attracted a great deal of 
attention as a semiconductor that is sensitive to visible light and has superior photocatalytic activity for 
environmental purposes, such as water treatment [17]. The traditional methods used to obtain Bi2O3 
require the addition of organic/toxic solvents and high temperatures [17,18]. Uddin et al. [19] reported 
the room temperature biosynthesis of monodisperse Bi2O3 nanoparticles (5–10 nm) by  
Fusarium oxysporum as an alternative to conventional chemical methods. An important advantage of 
this ecofriendly biosynthesis is the formation of Bi2O3 nanoparticles with a protein layer, in contrast to 
the delicate surface coating that is obtained by using the conventional chemical methods, which are not 
capable of providing thermal stability or avoiding the agglomeration of nanoparticles. 
2.2. Cobalt Oxide (Co3O4) Nanocrystals 
Co3O4 nanomaterials possess desirable optical, magnetic and electrochemical properties and have 
been used as a super capacitor in energy storage devices. The classical methods of synthesis are 
solvothermal and thermal decomposition and the use of templates [20–22]. These synthetic routes are 
costly, time-consuming and toxic.  
The microbial synthesis of Co3O4 nanoparticles using the marine bacterium Brevibacterium casei, 
was described by Kumar et al. [23]. This was likely the first study in which the quantitative and 
qualitative analyses that were conducted during the biogenic synthesis indicated the sensitivity of the 
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micromechanical properties of cells to the surrounding toxic environment. Transmission electron 
microscopy (TEM) of the as-synthesized nanoparticles revealed the quasi-spherical morphology of the 
particles with an average size of 6 nm. The protein coating on the biogenic Co3O4 nanoparticles 
reduced agglomeration and conserved the identity of the isolated nanoparticles [23]. 
2.3. Copper Oxide (CuO, Cu2O) Nanoparticles 
Copper and copper oxide nanoparticles are used in optical and electronics applications and are a 
promising antimicrobial agent [5,24]. Several researchers have described the biogenic synthesis of 
copper based nanoparticles for a variety of applications. Hasan et al. [25] demonstrated that  
Serratia sp. produces an intracellular mixture of metallic copper and different copper oxides. Copper 
oxide (Cu2O) nanoparticles (10–20 nm) were synthesized at room temperature using the baker’s yeast 
Saccharomyces cerevisiae [26]. The proposed mechanism is based on the partial gaseous hydrogen 
pressure of the reduction potential of metallic ions, which indicates the dependence of membrane 
bound oxido-reductases [26].  
Usha et al. [27] reported the synthesis of copper oxide by Streptomyces sp. for antimicrobial 
applications in textiles. Copper oxide nanoparticles (100–150 nm) were obtained in solution by the 
reduction of copper sulfate by the reductase enzymes of the microorganism. The authors demonstrated 
the antibacterial (against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus)) and 
antifungal (against Aspergillus niger) efficacies of nanoparticle-coated fabrics. Scanning electron 
microscopy (SEM) revealed nanoparticles embedded on the treated fabric textile. The durability of the 
finished fabric was evaluated [27]. Singh et al. [28] reported the biological synthesis (E. coli) of 
copper oxide nanoparticles with different sizes (10–40 nm, plus aggregates) and shapes  
(quasi-spherical). The results indicated the presence of a mixture of Cu2O and CuO phases. The 
proteins secreted by E. coli, with molecular weights ranging from 22 to 52 KDa, were attributed to 
reduced copper ions and stabilized the nanoparticle suspension [28].  
Fungi can also synthesize metallic oxide nanoparticles. The biogenic synthesis of copper oxides was 
performed using Penicillium aurantiogriseum, P. citrinum and P. waksmanii isolated from soil [29]. 
The authors investigated the effects of experimental parameters (pH and salt concentration) on the size 
of biogenic nanoparticles. SEM indicated a spherical shape of the nanoparticles [29]. Another green 
synthesis of Cu2O used Tridax procumbens leaf extract [30]. The resulting Cu2O nanoparticles were 
coated with polyaniline by a chemical polymerization technique. Hexagonal and cubic nanoparticles 
with rough surfaces were observed by SEM. The antibacterial effect of the Cu2O nanoparticles was 
evaluated against E. coli. A 65% inhibition of bacterial growth was observed upon the incubation of  
E. coli with 20 µg/cm3 of nanoparticles. A 100% inhibition was found for Cu2O concentrations in the 
range of 50–60 µg/cm3 [30]. Sangeetha et al. [31] produced mono-dispersed, versatile and highly 
stable CuO nanoparticles from Aloe vera extract. This method is both ecofriendly and inexpensive, and 
it produced spherical CuO nanoparticles with a size range of 15–30 nm [31].  
2.4. Iron Oxide (Fe2O3, Fe3O4) Magnetic Nanoparticles 
Magnetic iron oxide nanoparticles show potential in several biomedical applications, including drug 
delivery, hyperthermia and nuclear magnetic resonance imaging [2,32,33]. In addition to the classical 
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chemical methods of synthesis, there is an increasing interest in the use of biogenic techniques to 
obtain iron oxide nanoparticles [4].  
In the presence of anionic iron complexes, and under aerobic conditions, Actinobacter spp. yielded 
two new proteins that synthesize magnetite nanoparticles. The biotransformation of ferri-/ferrocyanide 
complexes into magnetite was dependent on the proteins secreted by this bacterium [34]. Incubating 
Actinobacter spp. with a ferricyanide/ferrocyanide mixture for 24 or 48 h resulted in quasi-spherical 
magnetite nanoparticles (10–40 nm) and cubic nanoparticles (50–150 nm), respectively. The 
nanoparticles were stable in aqueous solutions for several weeks because of the biomolecules secreted 
by the bacterium and were superparamagnetic at room temperature [34]. The mycelia of acidophillic 
fungi, Verticillium sp. and Fusarium oxysporum, extracellularly form magnetite when they are exposed 
to an aqueous solution of K3[Fe(CN)6] and K4[Fe(CN)6] [35].  
Shewanella strain HN-41, a dissimilatory iron-reducing bacterium, forms iron oxide, with formate, 
pyruvate or lactate as an electron donor, through the reduction of Fe(III)-oxyhydroxide, akaganeite  
(β-FeOOH) [36]. DNA-binding protein from the starved cells of the bacterium Listeria innocua, 
LiDps, and its triple-mutant lacking the catalytic ferroxidase centre LiDps-tm produced nanomagnets at 
the interface between molecular clusters and traditional magnetic nanoparticles in the presence of a 
ferroxidase center [37]. Yaaghoobi et al. [38] reported the biogenic production of magnetic iron oxide 
nanoparticles (≤104 nm) from Acinetobacter radioresistens. The authors compared the toxicity of 
biogenic and commercial iron oxide nanoparticles on red blood cells by evaluating hemagglutination, 
hemolysis and morphological changes. Severe hemagglutination was observed for commercial 
nanoparticles in a concentration-dependent manner from a concentration of 50 µg/mL. Toxic effects 
and morphological changes in the peripheral blood cells were not observed from bacterial synthesized 
magnetic iron oxide nanoparticles [38]. Biogenic ferrihydrite (Fe2O3 nH2O) nanoparticles that were 
synthesized by the bacteria Klebsiella oxytoca demonstrated composites in which amorphous or 
crystalline nanomaterials were observed with organic molecules [39–41]. Dissimilatory  
Fe(III)-reducing bacteria, such as Geobacter metallireducens and Shewanella putrifaciens, produce 
magnetite (nanocrystals) as a by-product of their metabolism in a growth medium [42].  
Byrne et al. [43] described the production of Fe3O4 nanoparticles by Geobacter sulphurreducens by 
modulating the total biomass used at the start of the synthesis. The authors observed that smaller 
particle sizes and narrower size distributions were achieved with higher concentrations of bacteria. 
This finding indicated that adjusting experimental parameters in the microbial synthesis of 
nanoparticles affects the physical, chemical and morphological properties of biogenic nanomaterials. 
Nanosized biogenic magnetite nanoparticles (10.0 ± 4.0 nm in diameter) were synthesized by the 
dissimilatory iron-reducing bacterium, Shewanella sp., for heterogeneous catalysis in ozonation [44]. 
Iron oxide nanoparticles were produced by tannins, a natural and non-toxic polyphenolic compound 
extracted from plants [45,46]. Herrera-Becerra et al. [45] described the biogenic synthesis of magnetic 
hematite (Fe2O3) nanoparticles with a size less than 10 nm and pH 10 using tannins. Phenolic 
compounds, acting as capping agents, improve stabilization of the colloidal suspension and avoid 
nanoparticle aggregation.  
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2.5. Antimony Oxide (Sb2O3) Nanoparticles 
As an inorganic semiconductor compound, antimony (III) oxide (Sb2O3) has several applications in 
technology and in chemical catalysis [47]. Jha et al. [48,49] reported the low-cost reproducible 
biosynthesis of Sb2O3 nanoparticles at room temperature in the presence of baker’s yeast  
(S. cerevisiae). Different characterization techniques revealed the formation of Sb2O3 nanoparticles in 
a face-centered cubic unit cell structure, with an average size of 3–12 nm [48].  
2.6. Silica (SiO2) Nanoparticles 
Silica nanoparticles are important nanomaterials in biomedical applications such as nanocarriers for 
drug delivery systems [50,51]. Silica nanoparticles are widely used in industry, biomedical engineering 
and cosmetics [52]. 
In the presence an aqueous solutions of K2SiF6 (pH 3.1), mycelia of Fusarium oxysporum led to the 
formation of silica nanoparticles that ranged in diameter from 5 to 15 nm with an average size of  
9.8 ± 0.2 nm [53]. The authors demonstrated that the fungus Fusarium oxysporum secretes proteins 
that extracellularly hydrolyze SiF62−, yielding silica nanoparticles at room temperature [53]. 
Actinobacter sp. cells were harvested and washed with water under sterile conditions and resuspended 
in an aqueous solution of K2SiF6. They formed quasi-spherical silicon/silica (Si/SiO2) nanoparticles 
with an average size of 10 nm [54]. The cytotoxicity of the Si/SiO2 nanocomposites towards human 
skin cells was evaluated because silica nanoparticles are used in applications that require direct skin 
contact [54]. The results demonstrated that the particles are not toxic to human skin cells [54].  
2.7. Titanium Dioxide (TiO2) Nanoparticles 
TiO2 nanoparticles have important environmental, technological and biomedical  
applications [51,55]. Jha and Prasad [56] reported the reproducible room temperature biosynthesis of 
TiO2 nanoparticles (10–70 in size) by Lactobacillus sp. that were obtained from yogurt and probiotic 
tablets. In the presence of suitable carbon and nitrogen sources, lactobacillus or yeast cells interact 
with a TiO(OH)2 solution to produce TiO2 nanoparticles (8–35 nm) with few aggregates [57]. 
Lactobacilli have a negative electrokinetic potential, which is suitable for the attraction of cations, a 
step that is required for the biosynthesis of metallic nanoparticles. 
2.8. Uraninite (UO2) Nanoparticles 
Nanoparticles of UO2 are important for nuclear applications. The reduction of soluble uranium salts 
by microbial agents represents an important part of the geochemical cycle of this metal and highlights 
a mechanism for the bioremediation of uranium contamination [58,59]. Dissimilatory metal- and  
sulfate-reducing bacteria, such as Desulfovibrio desulfuricans, results in the precipitation of biogenic 
UO2 (bio-UO2) [58–60]. Biogenic uraninite was anaerobically produced by Shewanella oneidensis 
strain MR-1, at pH 6.3 [UO2(CO3)22−] and 8.0 [UO2(CO3)34−] [61]. Shewanella putrefaciens interacts 
with U(VI) reductases and biogenic U(IV) on the cell surface with uranium salt. Uraninite particles 
accumulate on extracellular polymeric substances [62]. The average particle size was 3 nm, as 
determined by high-resolution transmission electron microscopy (HRTEM) and X-ray absorption 
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spectroscopy. Scanning electron microscopy (SEM) analysis revealed that nanoparticles exhibit 
extracellular accumulation [62]. The synthesis of biogenic UO2 nanoparticles (5–10 nm) was mediated 
by S. putrefaciens cell suspensions growing aerobically, followed by the anaerobic addition of a 
uranyl-bearing solution [(UO2+2)-PIPES,NH4Cl–lactate–KHCO3–K2HPO4] [63]. 
2.9. Zinc Oxide (ZnO) Nanoparticles 
Prasad and Jha [64] reported mild conditions for the biosynthesis of ZnO nanoparticles (5–15 nm) 
by the probiotic microbes Lactobacillus sporoge. The biogenic ZnO nanoparticles demonstrated the 
promising application of decontamination with corrosive and highly toxic hydrogen sulfide gas [64]. 
2.10. Zirconia (ZrO2) Nanoparticles 
Zirconia nanoparticles are used as an electro-optic, piezoelectric and dieletric material because of 
their physicochemical features [65]. They are also an efficient catalyst [66]. Zirconia nanoparticles 
(average size of 8 nm) were biosynthesized at room temperature by challenging the fungus  
F. oxysporum with aqueous ZrF62− anions [66]. Cationic proteins (molecular weight 24 to 28 kDa) 
were reported to perform the extracellular hydrolysis of metal anions to ZrO2 nanoparticles [66].  
2.11. Tin oxide (SnO2) Nanoparticles 
SnO2 nanoparticles (average size of 3 nm) were successfully synthesized through a novel biogenic 
synthesis method using Saraca indica flower extract as a reducing agent [67]. Biogenic SnO2 
nanoparticles demonstrated antibacterial activity against E. coli and antioxidant properties, as assayed 
by scavenging the free radical of 2,2-diphenyl-1-picrylhydrazyl hydrate. These particles demonstrate 
promise in biomedical applications [67].  
3. Nanotoxicity of Metal Oxide Nanoparticles  
Although a wide range of biogenic metallic nanoparticles have been investigated, few papers have 
reported the toxicity of these nanoparticles. The literature discusses the synthesis and characterization 
of biogenically synthesized metal oxide nanoparticles. To develop applications using metal oxide 
nanoparticles that are synthesized either by biogenic or classical methods, a detailed investigation of 
the human and environmental toxicity of these nanoparticles is required. This section summarizes the 
toxicity of different metal oxide nanoparticles synthesized by biogenic and chemical/physical 
techniques. Because of the importance of metallic nanoparticles, the nanotoxicology of these materials 
should be further characterized.  
3.1. Bismuth Trioxide (Bi2O3) Nanocrystals 
Bismuth trioxide is not toxic to human tissue [68]. However, its chemical synthesis is complex and 
requires extreme conditions. Ionic bismuth is reduced by sodium borohydride and is then oxidized at 
high temperatures [3]. Biogenic synthesis is an ecofriendly methodology that is widely acceptable. No 
reports have described the toxicity of Bi2O3 nanoparticles, which indicates the necessity of 
investigating this area of nanotoxicology. Zhu et al. [69] described the preparation of hybrid nanogels 
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composed of Bi2O3 quantum dots incorporated into a nanogel of poly(vinyl alcohol) (PVA). The 
incubation of Bi2O3@PVA hybrid nanogels for 24 h with mouse melanoma B16F10 cells resulted in 
the incorporation of the metallic nanoparticles into the perinuclear and cytoplasm of the cells. No 
morphological damage was observed. A cytotoxicity evaluation demonstrated that more than 96% of 
the B16F10 cells survived in concentrations of up to 200 µg/mL of the hybrid nanogels [69]. These 
results indicate that this hybrid nanomaterial may be used in biomedical applications such as optical 
surgery, fluorescence detection and imaging diagnosis with minimal cytotoxic effects. The cytotoxicity 
of bare Bi2O3 nanoparticles alone was not evaluated.  
3.2. Cobalt Oxide (Co3O4) Nanocrystals 
Co3O4 nanoparticles, synthesized by thermal decomposition, exert oxidative stress on human 
lymphocytes, damage DNA, and cause inflammatory responses [70]. Oxidative stress is an important 
factor for toxicity and causes the induction of apoptosis. The authors assumed that Co2+ ions, when 
released from cobalt oxide nanoparticles, are the primary source of toxicity through the induction of 
TNF--caspase-8-p38-caspase-3 in immune cells [70]. Co3O4 nanoparticles induced cytotoxicity, 
morphological transformation, and genotoxicity in Balb3T3 cells [71,72]. Co-nanoparticles induce 
genotoxic effects in human peripheral leukocytes [73]. All of these effects were most likely because of 
cobalt ion dissolution from the nanoparticles. Bare Co3O4 nanoparticles are toxic towards primary 
human immune cells and affect human health. Surface modification (e.g., protein corona) may open 
the gateway for the use of Co3O4 nanoparticles in different areas [70].  
The toxicity of Co3O4 nanoparticles were demonstrated in BEAS-2B cells, which are a model of 
airway epithelium of normal lung tissues [74]. Low soluble cobalt oxide nanoparticles were readily 
internalized by human lung cells through endocytosis via a clathrin-dependent pathway. Several 
techniques demonstrated that incorporated Co3O4 nanoparticles are partially solubilized within cell 
lysosomes because of the low pH. There, the toxic cobalt ions are released from the nanoparticles  
(Figure 2) [74]. The authors suggested that the cytotoxic effects of cell incubation with cobalt oxide 
nanoparticles can be attributed to the release of Co2+ within the lysosome and/or oxidative stress 
because of the direct effects of metallic cobalt nanoparticles [74]. The toxicity of Co3O4 nanoparticles 
and cobalt ions was assayed in human umbilical vein endothelial (ECV-305) and human liver 
carcinoma (HepG2) cell lines [75]. Although cobalt metal oxide nanoparticles led to time- and 
concentration-dependent cytotoxicity, free Co2+ ions were more toxic. The induction of reactive 
oxygen species (ROS) was observed from Co3O4 nanoparticles, rather than Co2+ ions. Cellular uptake 
experiments demonstrated that metallic nanoparticles were readily internalized in vesicles inside the 
cytoplasm [75].  
A previous report suggested that commercial bare Co3O4 nanoparticles associated to ovalbumin, as 
a protein corona, stimulated low allergic antibody production and in vivo inflammation (at both the 
subcutaneous and intraperitoneal antigen administration sites). Lower in vitro toxicity was observed 
while stimulating both Th1 and Th2 in vivo antibody responses, which indicated that Co3O4 
nanoparticles maybe used as a vaccine adjuvant [76]. This finding is important for biogenic Co3O4 
nanoparticles because they are naturally capped with protein during the biogenic synthesis  
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process. Studies that investigate the toxicity of biogenically synthesized cobalt oxide nanoparticles  
are necessary.  
 
Figure 2. Schematic representation of the analytical methods and the quantification of 
cobalt internalized in cell compartments. IC25: inhibiting concentration 25%; Micro-PIXE:  
particle-induced X-ray emission; ICP-MS: inductively coupled plasma mass spectrometry. 
Reproduced from reference 74 with permission of the BioMed Central Ltd. 
3.3. Copper Oxide (CuO, Cu2O) Nanoparticles 
The human lung epithelial cell line A549 was exposed to different nanomaterials including  
CuO [77]. Cytotoxicity was analyzed using trypan blue staining. DNA damage and oxidative lesions 
were determined using the comet assay, and the intracellular production of ROS was measured using 
the oxidation sensitive fluoroprobe 2',7'-dichlorofluorescin diacetate (DCFH-DA). CuO nanoparticles 
exerted a strong effect regarding cytotoxicity, DNA damage and ROS generation. The effects were not 
explained by soluble metal impurities [77]. CuO nanoparticles induced dose-dependent toxic effects at 
the biochemical, physiological and tissue levels in the blue mussel (Mytilus edulis) [78].  
Microorganisms have been used to predict the potential nanotoxicity of metal oxide nanoparticles 
because of their functions in biogeochemical cycling in nature [79]. The antibacterial activity of copper 
oxide nanoparticles was reported. Usha et al. [27] demonstrated the biosynthesis of copper oxide 
nanoparticles by a Streptomyces sp. that interacted efficiently against E. coli, S. aureus, and 
Aspergillus niger after 48 h of incubation. Gopalakrishnan et al. [30] also reviewed the antibacterial 
nature of biologically synthesized cuprous oxide by plants against E. coli. 
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Laha et al. [80] synthesized CuO nanoparticles (30 nm) by biophysical methods, and reported that 
CuO nanoparticles induced autophagy in a human breast cancer cell line (MCF7) in a time- and  
dose-dependent manner. Siddiqui et al. [81] reported that CuO nanoparticles (average size 22 nm) 
induced cytotoxicity in human hepatocellular carcinoma (HepG2) cells in a dose-dependent manner  
(2–50 mg/mL) and reported that tumor suppressor gene p53 and apoptotic gene caspase-3 were 
upregulated upon exposure to CuO nanoparticles. Figure 3A shows the field emission transmission 
electron microscopy (FETEM) image (inset with a higher magnification) of CuO nanoparticles. The 
nanoparticles are a spherical shape with smooth surfaces, and the inset of Figure 3A revealed the 
crystalline nature of the CuO nanoparticles. Figure 3B reports the viability of HepG2 cells, as assayed 
by (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT), incubated for 24 h with 
CuO nanoparticles at different concentrations up to 50 µg/mL. Cell viability was significantly reduced 
in a concentration-dependent manner (83%, 69%, 52%, 34% and 28%) when the cells were exposed to 
varying concentrations of CuO nanoparticles (2, 5, 10, 25 and 50 mg/mL) [81].  
 
Figure 3. (A) Field emission transmission electron microscopy (FETEM) image (inset 
with higher magnification) of CuO nanoparticles. (B) Cytotoxicity of CuO nanoparticles in 
hepatocellular carcinoma cell line (HepG2) cells assayed by MTT. Incubation for 24 h at 
different nanoparticle concentrations. * Statistically significant difference compared with 
the controls (p < 0.05). Modified from reference 81 with permission of the PLoS One. 
Sun et al. [82] exposed the A549, H1650 and CNE-2Z cell lines to chemically synthesized CuO 
nanoparticles and reported high toxicity on cell viability. The authors observed that the autophagic 
biomarker LC3-II significantly increased in A549 cells treated with CuO nanoparticles. The use of the 
autophagy inhibitors such as wortmannin and 3-methyladenin significantly improved cell  
survival [82]. These results indicate that the cytoxicity of CuO nanoparticles may involve the 
autophagic pathway in A549 cells. These results support the results reported by Laha et al. [80], in 
which CuO nanoparticles were incubated with cancer cells. 
These papers refer to the cytotoxicity of chemically synthesized copper oxide nanoparticles. 
Biogenic copper oxide nanoparticles (100–150 nm) that were produced by Streptomyces sp. were 
applied to antimicrobial textiles. The cotton fabrics with copper nanoparticles displayed the maximum 
zone of mycostasis [27]. These results indicate the promising applications of copper oxide 
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nanoparticles in clothing that reduces the transmission of infectious agents. The green synthesis of 
CuO nanoparticles from gum karya, a natural nontoxic hydrocolloid, demonstrated significant 
antibacterial actions against E. coli and S. aureus [83]. The smaller (4.8 ± 1.6 nm) CuO nanoparticles 
yielded a maximum zone of inhibition compared to the larger size (7.8 ± 2.3 nm) nanoparticles. The 
minimum bacterial concentrations for CuO nanoparticles, with an average size of 4.8 nm, were  
125 ± 5.5 µg/mL for E. coli and 135 ± 8.8 µg/mL for S. aureus [83]. CuO nanoparticles (5–45 nm) 
produced using brown alga (Bifurcaria bifurcata) extract demonstrated antibacterial activity against 
Enterobacter aerogenes and Staphylococcus aureus [84]. Biogenic CuO nanoparticles (average size of 
20 nm), which were obtained by using Phyllanthus amarus leaf extract, showed antibacterial activity 
on multidrug resistance bacteria such as both Gram-positive (B. subtilis and S. aureus) and  
Gram-negative (E. coli and P. aeruginosa) bacteria [85]. Copper oxide nanoparticles (48 ± 4), 
synthesized by using Tabernaemontana divaricate leaf extract, showed antimicrobial activity against 
urinary tract pathogens (the maximum inhibition was 50 µg/mL of nanoparticles against E. coli) [86].  
These results demonstrated that chemically synthesized copper oxide nanoparticles are toxic to 
human cells. Some research has described the antibacterial actions of biogenically obtained copper 
oxide nanoparticles. The cytotoxicity of these biogenic nanoparticles in human cells should  
be evaluated. 
3.4. Iron Oxide (Fe2O3, Fe3O4) Nanoparticles 
Iron oxide nanoparticles, such as magnetite (Fe3O4) and hematite (Fe2O3), have many important 
biomedical and industrial applications [2,4]. Nanotoxicology has become increasingly important. The 
toxicity of iron oxide nanoparticles has been evaluated through in vitro assays, although in vivo assays 
are becoming important [87].  
In vitro studies of magnetosomes (membrane-enclosed inorganic crystals consisting of either the 
magnetic mineral magnetite (Fe3O4) or greigite (Fe3S4)) from Magnetospirillum gryphiswaldense with 
mouse fibroblast cells revealed the non-toxicity of the nanoparticles [88]. A review by Lang and  
Schuler [89] highlighted the important in vitro applications of bacterial magnetic nanoparticles  
(e.g., magnetic separation and procedures for labeling and immobilization of various biomolecules), 
and their environmental importance. These results demonstrated the biotechnological and 
nanotechnological potentials of bacterial magnetic nanoparticles [89]. Most papers have described the 
in vitro and in vivo toxicity of chemically and/or physically synthesized iron oxide  
nanoparticles [32,87,90,91]. The toxicity of iron oxide nanoparticles can be attributed to the ROS 
induction of oxidative stress [92], and it is dependent on the particle surface, size distribution, zeta 
potential, and the chemical nature of the surface coating [32,87].  
An interesting study compared the cytotoxicity of synthetic and biogenic magnetite on L929  
cells [93]. Co-precipitation was used to obtain the traditional iron oxide nanoparticles, and the biogenic 
nanoparticles were synthesized by magnetosomes isolated from MSR-1. The average particle size of 
the chemically synthesized magnetite nanoparticles was from 7 to 18 nm, whereas a 10 to 60 nm size 
was observed for the magnetosomes. Both biogenic and chemically synthesized nanoparticles affected 
the metabolic activity of L929 cells in a concentration- and time-dependent manner (with a 
concentration range of 0.5–1.0 mg/mL and an incubation time of 24 to 72 h). However, cell viability of 
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L929 exposed to synthetic iron oxide nanoparticles was 85%, whereas 90% was observed for biogenic 
magnetite; both exposures occurred at 1.0 mg/mL and with 72 h of incubation [93]. The authors 
assumed that the presence of a lipid membrane on the magnetosomes’ surface increased the 
biocompatibility of the nanomaterial in comparison with chemically synthesized nanoparticles [93].  
The toxicities of commercial and bacterial (Acinetobacter radioresistens) magnetic iron oxide 
nanoparticles on peripheral blood cells were evaluated by monitoring hemagglutination, hemolysis and 
morphological changes [38]. The authors observed lysis at low nanoparticle concentrations and severe 
hemagglutination in samples treated with commercial nanoparticles (50 µg/mL). Biogenic synthesized 
iron oxide nanoparticles did not induce morphological changes in peripheral blood cells [38]. These 
results indicate that biogenic iron oxide nanoparticles are less toxic than chemically generated iron 
oxide nanoparticles. However, further investigation is required.  
3.5. Antimony Oxide (Sb2O3) Nanoparticles  
Antimony trioxide (Sb2O3) is primarily used as a flame retardant in rubber, paper, pigments, 
adhesives, and plastics, among other materials. Antimony trioxide treatment was associated with the 
increased apoptosis associated with the induction of ROS and differentiation markers [94]. Apoptosis 
is increased upon the depletion of glutathione levels, and an increase of ROS in cells [94].  
Bregoli et al. [95] reported the toxicity of Sb2O3 nanoparticles (5 µg/mL) on the proliferation of human 
hematopoietic progenitor cells. Sb2O3 nanoparticles were not toxic towards seven human cell lines of 
hematopoietic origin, which indicated that cell lines and primary cells (human hematopoietic 
progenitor cells) respond differently [95]. No studies have examined the toxicity of biogenically 
synthesized Sb2O3.  
3.6. Silica (SiO2) Nanoparticles 
Several papers have described the toxicity of silica nanoparticles [50]. The nanotoxicity of 
amorphous SiO2 nanoparticles (10 nm) on human lung submucosal cells is associated with 
inflammation, release of ROS leading to apoptosis, and decreased cell survival [96]. The decreased 
viability of human airway epithelial cell line (Calu-3) exposed to SiO2 nanoparticles (concentrations up 
to 50 µg/mL) for 2 to 24 h was reported in a concentration- and time-dependent manner. The nanotoxic 
effect of SiO2 nanoparticles was significantly attenuated by the flavonoid fisetin or catalase treatments, 
which indicated the oxidative stress mechanism for the toxicity of silica nanoparticles. Figure 4 shows 
the percentage of Calu-3 viability upon treatment with 25 or 50 µg/mL of SiO2 nanoparticles. In  
Figure 4A, Calu-3 cells were incubated with SiO2 nanoparticles in the absence or presence of fisetin  
(10–80 µg/mL) for 24 h. Catalase also attenuated the decrease of cell viability caused by SiO2 
nanoparticles (Figure 4B). The authors demonstrated that the toxic effects of SiO2 nanoparticles were 
because of the oxidative stress via ROS production [96].  
The toxicity of commercially available SiO2 nanoparticles (10 and 300 nm) was investigated in the 
RAW 264.7 mouse macrophage cell line [97]. The authors observed that 10 nm SiO2 nanoparticles 
affected cell proliferation, morphology and cell cycle. A significant increase in TNF-α level was 
reported for RAW 264.7 cells exposed to SiO2 nanoparticles at a concentration of 0.01 g/L for 24 h. 
The 10 nm silica nanoparticles were internalized into the cells, whereas 300 nm silica nanoparticles 
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were poorly internalized. Cells treated with smaller SiO2 nanoparticles greatly reduced phagocytosis, 
as monitored by the RAW 264.7 cells’ uptake of E. coli. The bioaccumulation of small SiO2 
nanoparticles within macrophages may suppress bacterial uptake and impair antibacterial activity [97].  
 
Figure 4. Cell viability of Calu-3 upon incubation with SiO2 nanoparticles. (A and B) Prior 
incubation of cells with fisetin (A) and catalase (B) prevented the cell death induced by  
SiO2-nanoparticles (25 and 50 μg/mL) on Calu-3. * p < 0.05, ** p < 0.01, and  
*** p < 0.001, n = 3–4. Modified from reference 96 with permission of the American 
Chemical Society. 
A recent in vivo study evaluated the toxic effects of suspensions of commercial silica nanoparticles 
(333 mg/kg/day, 10–15 nm) in Wister mice administered via oral gavage [98]. The authors reported 
significant changes in cholesterol, urea, total protein, LDL, HDL, aspartate aminotransferase activity 
and alkaline phosphatase activity. Histological evaluations revealed toxic effects on different tissues, 
such as lung, liver, testes and kidney [98]. Opposite results were reported by Kim et al. [99]. The  
in vivo toxicity of commercially obtained SiO2 nanoparticles (20 and 100 nm) and average zeta 
potential of −40 mV were administered orally by gavage in Sprague-Dawley rats for 14 days. The 
doses ranged from 500 to 2000 mg/kg. The results of a 90-day toxicity evaluation demonstrated no 
clinical or histopathological changes compared with the control group. Further studies are required to 
understand the in vivo toxicity of SiO2 nanoparticles.  
In vitro studies reported the cytotoxicity of commercially available SiO2 nanoparticles on human 
mesenchymal stem cells for several concentrations (25–400 µg/mL) and incubation times  
(24–72 h) [100]. The metabolic stress of the cells was determined by alterations in the nuclear 
morphology, cytoplasm organization, and changes in gene expression [100].  
Biogenically synthesized Si/SiO2 nanocomposites (Actinobacter sp.) did not display cytotoxic 
effects to human epithelial cells (A431 cell line), which indicates that these biogenic nanoparticles may 
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be useful in biomedical applications [54]. A431 cells were incubated with different concentrations of 
biogenically synthesized Si/SiO2 nanocomposites (50 µmol/L to 10 mmol/L) for 3 h. Further studies 
with longer incubation times (at least 24 h) are necessary to better investigate the potent toxic effects 
of silica nanoparticles. The authors observed a toxic effect, measured as the percentage decrease of 
mitochondrial activity, for cells that were incubated with the higher concentrations of the Si/SiO2 
nanocomposite. The percentages of mitochondrial activity were 14.74% and 37.5% for 10 mmol/L and 
5.0 mmol/L of the silica-based nanomaterial. Mitochondrial activity was more than 68% for cells 
incubated with 1.0 to 50 mmol/L of Si/SiO2 nanocomposite. The concentration-dependent toxic effects 
of biogenic silica nanoparticles were also observed by the drastic changes in skin cell morphology that 
occurred upon treatment with 10 and 5.0 mmol/L of the nanomaterial [54].  
3.7. Titanium Dioxide (TiO2) Nanoparticles 
Titanium dioxide nanoparticles (TiO2) are one of the most widely used nanostructures in various 
areas. The study of the potential toxicity of this metal oxide nanoparticle has gained increasing  
attention [101]. Sheng et al. [102] showed demonstrated that 90 days of increased doses (2.5 to  
10 mg/kg body weight) of intragastrically administered TiO2 nanoparticles resulted in spleen damage 
and immune dysfunction in mice. The authors also reported alterations in the expression of genes 
related to stress responses, cell proliferation, apoptosis, metabolic processes, and oxidative  
stress [102].  
Regarding to biogenic nanoparticles, environmentally isolated Bacillus mycoides was used to 
synthesize anatase polymorphic TiO2 nanoparticles (40–60 nm) with spherical morphologies for efficient 
green solar cells [103]. The biogenic nanoparticles exhibited no toxicity on E. coli cultures [103].  
An antibacterial effect against E. coli was reported for biogenically synthesized TiO2 nanoparticles  
(62–74 nm) with a spherical/oval shape obtained from the fungus Aspergillus flavus [104]. The 
minimum inhibitory concentration value was 40 µg/mL for E. coli treated with fungus-mediated 
synthesized TiO2 nanoparticles [104]. The antibacterial activity of biogenically synthesized TiO2 
nanoparticles (28–54 nm) that were obtained from the bacteria Aeromonas hydrophila was reported for  
S. aureus and S. pyogenes [105]. Therefore, biogenically synthesized TiO2 nanoparticles can have 
contradictory antibacterial effects, depending on the biological reducing and capping agent that is 
employed during the biogenic synthesis processes. These results indicate that this phenomenon 
requires further investigation.  
The biocompatibility of biogenically synthesized TiO2 nanoparticles was reported by  
Babitha et al. [106]. TiO2 nanoparticles were obtained by a metal-resistant bacterium isolated from 
coal fly ash effluent. The nanoparticles had an anatase phase, a spherical shape with a smooth surface 
and a size in the range of 15–80 nm. No hemolysis or cell death of NIH/3T3 cell lines were reported 
when the cells were incubated with up to 100 µg/mL of TiO2 nanoparticles, which indicated the 
biocompatibility of the biogenic nanoparticles. In vivo wound healing studies on Wister rats revealed 
that biogenic TiO2 nanoparticles accelerated the tissue repair process. Complete wound closure was 
demonstrated for rats that were treated with collagen films containing 25 µg/mL of biogenic TiO2 
nanoparticles. Wound closure occurred after 18 days of treatment for the control group (rats treated 
with only collagen film) 106.  
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3.8. Uraninite (UO2) Nanoparticles  
Uranium oxide and uranyl nitrate have different toxicities. Uranyl nitrate is soluble in water and 
moderately soluble in body fluids, and it is readily transported into the body organs or absorbed 
through the skin, which leads to bioaccumulation and toxicity. The kidney is the most damaged  
organ [107,108]. Uranium oxide is largely insoluble. Only small particles are deposited in the 
pulmonary region of the lung and retained for long periods, which leads to radiological consequences. 
Because UO2 can be soluble in aqueous HCl, some ingested UO2 nanoparticles could be absorbed in 
stomach, resulting in toxic effects [107,108]. Inhalation of aerosol containing uranium particles was 
slow in in vivo experiments with rats (half-life of 141.5 days) [109].  
Monleau et al. [110] demonstrated that the DNA strand breaks in the lungs of rats that occurred 
after acute and chronic exposures to depleted uranium by inhalation were the consequence of oxidative 
stress and the induction of pro inflammatory IL8 and TNFα. These effects may be linked to the 
depleted uranium doses and independent of the solubility of uranium oxide [106]. The 
biotransformations of uranyl salts are an important way to avoid environment contamination, and the 
presence of protein capping on the surface of biogenically synthesized UO2 nanoparticles can avoid 
posterior metal solubilization [63]. Lee et al. [111] reported the biogenic synthesis of UO2 (uraninite) 
nanocrystals by the iron-reducing bacterium, Shewanella putrefaciens CN32, from uranium-rich 
solution. A recent review [112] discussed the importance of bioreduction processes in which bacteria 
enzymatically reduce aqueous U(VI) (toxic) to insoluble U(IV) (less toxic) coupled with the oxidation 
of an organic electron donor [112]. Therefore, microorganisms play a key role in the environmental 
decontamination of soluble U(VI) by its reduction to the poorly soluble mineral uraninite  
(UO2) [58,59,62,112].  
3.9. Zinc Oxide (ZnO) Nanoparticles  
Aspergillus terreus culture filtrate was used for the extracellular biosynthesis of zinc oxide 
nanoparticles (55–83 nm). The biogenic zinc oxide nanoparticles demonstrated antifungal activity 
against selected fungal species (A. niger, A. fumigatus and A. aculeatus) [113]. ZnO2 nanoparticles 
were employed as antimicrobial agents and were incorporated into materials such as textiles and 
personal care items [114]. Green synthesized zinc nanoparticles (size 16–108 nm), using leaves of 
Parthenium hysterophorous, demonstrated enzymatic and microbial activity [115]. The physiological 
parameters, which were related to the growth of Arachis hypogea L. pot culture, increased from 30 to 
60 days of sowing compared with the control group. Therefore, biogenic ZnO nanoparticles with 
microbial activity may have applications in agriculture, where zinc is one of the essential 
micronutrients that need to be supplied to the crop [115].  
The antibacterial properties of green-synthesized ZnO nanoparticles were demonstrated against 
Gram-negative (Salmonella paratyphi, Escherichia coli, Vibrio cholerae) and Gram-positive  
(Staphylococcus aureus) bacteria using zone inhibition methods [116]. The biogenic ZnO nanoparticles, 
which had an average size of 30 nm and quasi-spherical shape, were obtained from the leaf extract of 
Solanum nigrum [116].  
Metals 2015, 5 949 
 
 
Concerning to the toxicity of biogenic ZnO nanoparticles, recently, Darroudi et al. [117] reported 
the cytotoxic effect of ZnO nanopowder obtained from gelatin. The nanoparticles (1.5–100 µg/mL) 
were toxic when incubated with neuro2A cells (a fast-growing mouse neuroblastoma cell line) for  
24 h. Cell viability was decreased in a dose-dependent manner when nanoparticles were administered 
at a concentration greater than 2 µg/mL [117]. In a similar study, Tabernaemontana divaricate leaf 
extract was employed to synthesize zinc oxide nanoparticles (average size 36 nm) [86]. The biogenic 
nanoparticles showed potent cytotoxic effects against MCF-7 breast cancer cell lines, with an IC50 
value of 30.65 µg/mL after 24 h of treatment [86]. The IC50 value for biogenic ZnO nanoparticles was 
lower than that of biogenic copper oxides that were synthesized by the identical plant extract [118]. 
ZnO nanoparticles can have antimicrobial and anticancer activities. However, the toxicity of these 
nanoparticles towards human cell lines must be investigated.  
3.10. Zirconia (ZrO2) Nanoparticles  
Zirconium oxide nanoparticles have been used in several skin care products such as cosmetics, 
deodorants and topical ointments, and they have showed significant toxicity [119]. One important 
application of ZrO2 is in composites for dental technology [120]. Li et al. [121] investigated the effect 
and biocompatibility of 20 wt% ZrO2 nanoparticles (50–75 nm) of white Portland cement [121]. The 
presence of ZrO2 nanoparticles enhanced the degree of hydration by 26% and displayed a positive 
effect on the in vitro biocompatibility of MG63 osteosarcoma cells [121]. Therefore, ZrO2 
nanoparticles are considered an important material for cement dental restoratives by increasing the 
hydration rate without cytotoxic effects. However, further investigation is necessary to establish the 
influence of ZrO2 nanoparticles in other dentistry applications. ZrO2 nanoparticles are also important 
in orthopedic implants. The carcinogenicity and chronic toxicity of ZrO2 containing yttrium oxide was 
evaluated by implanting solid rods into the thigh muscle of C57BL/6N mice for 24 months. No 
evidence of toxic effects was observed [119,122]. ZrO2, acting on the bacterial strains of E. coli, S. 
aureus and fungal strain of A. niger, exhibited activity against only the E. coli [123]. There is no report 
that describes the toxicity of biogenically synthesized ZrO2 nanoparticles.  
3.11. Tin Oxide (SnO2) Nanoparticles  
Biogenic tin oxide nanoparticles (spherical in shape with a size range of 2–4 nm) were synthesized 
from the Saraca indica flower [67]. SnO2 nanoparticles exhibited antibacterial activity against the  
Gram-negative bacteria E. coli. The mechanism for the antibacterial activity of SnO2 nanoparticles 
may be the efficient reaction of the metal oxide nanoparticles with the cell wall, which leads to the 
inactivation of the bacteria. The antioxidant activity of SnO2 nanoparticles was demonstrated by 
scavenging the free radical of 2,2-diphenyl-1-picrylhydrazyl hydrate. Biogenic SnO2 nanoparticles are 
a promising antibacterial agent and an antioxidant for pharmaceutical applications [67]. 
Biogenic SnO2 nanoparticles (spherical in shape with an average size of 20 nm) were obtained from 
the aqueous extract of the agricultural waste dried peel of a sugar apple (Annona squamosa) [124]. The 
cytotoxicity of biogenic SnO2 nanoparticles was evaluated against a hepatocellular carcinoma cell line 
(HepG2). SnO2 nanoparticles inhibited the cell proliferation in a dose- and time-dependent manner.  
The IC50 value was 148 µg/mL. Increased concentrations of SnO2 nanoparticles altered the cell  
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morphology [124]. The genotoxicity of SnO2 nanoparticles and immobilized amylase SnO2 nanoparticles 
were investigated [125]. The authors reported that 90% of enzyme activity was retained upon  
amylase immobilization on SnO2 nanoparticles, and no DNA damage was observed in lymphocytes for 
SnO2 and amylase-SnO2 nanoparticles [125]. These results indicate the biocompatibility of  
SnO2 nanoparticles.  
4. Relative Toxicity of Metal Oxide Nanoparticles  
Several studies have compared the toxicity of different metal oxide nanoparticles, but not 
biogenically synthesized nanoparticles. CuO, followed by ZnO, is reported to be the most toxic 
nanoparticle TiO2 is the least toxic nanoparticle.  
Cho et al. [126] compared the in vivo acute lung inflammogenicity and in vitro cytoxicity of CuO, 
SiO2, ZnO, and Co3O4 nanoparticles. CuO and ZnO were the most toxic nanoparticles in both in vitro 
and in vivo assays. Figure 5 shows the cytotoxicity of A549 cells after exposure to different 
nanoparticles for 24 h. Cell death was measured by trypan blue staining or lactate dehydrogenase 
(LDH) levels [126].  
 
Figure 5. Cytotoxicity of several metal oxide nanoparticles on A549 cells after 24 h of 
nanoparticle treatment. Cytotoxicity was assayed by trypan blue exclusion for ZnO and 
CuO nanoparticles. Other particles were assayed by lactate dehydrogenase (LDH). The 
surface area doses were 30, 100, and 300 cm2/mL for all nanoparticles, with exception of 
CuO and ZnO nanoparticles, which were 3, 10, and 30 cm2/mL. Values are mean ± SD 
from a minimum of four independent experiments. Significance versus vehicle control 
(VEH): * p < 0.05, *** p < 0.001. CB = Carbon back. Reproduced from reference 126 with 
permission of the BioMed Central Ltd.  
Different cell lines, including A549, were incubated with metal oxide nanoparticles. CuO was the 
most toxic, ferric oxide and TiO2 nanoparticles exhibited slight toxicity and SiO2 nanoparticles 
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resulted in mild toxicity [82]. Cell death induced by CuO nanoparticles was assigned to the autophagic 
pathway (cellular auto-digestion), mitochondria damage and oxidative stress [82]. The in vivo toxicity 
of ZrO2 and SiO2 nanoparticles was monitored upon oral administration to rats for 28 days in a dose of 
1000 mg of the nanoparticles/kg body weight/day [127]. ZrO2 and SiO2 nanoparticles did not cause 
significant systemic or local effects.  
Concerning to microbial toxicity of metal oxide nanoparticles, Baek et al. [128] investigated the 
toxicity of CuO, ZnO and Sb2O3 nanoparticles on S. aureus, E. coli and Bacillus subcillus. CuO 
nanoparticles were the most toxic because this material significantly reduced the colony forming units, 
followed by ZnO and Sb2O3 nanoparticles. The higher toxicity of CuO was demonstrated by  
Dasai et al. [129]. The authors compared the toxicity of different metal oxide nanoparticles to E. coli, 
both in the dark and under irradiation, in terms of the oxidative stress, amount of reduced glutathione, 
release of metal ions and lipid peroxidation. Under dark condition, the ranking of toxicity was  
ZnO > CuO > Co3O4 > TiO2. Under light irradiation, the toxicity was ZnO > CuO > TiO2 > Co3O4.  
In both cases, ZnO was the most toxic, followed by CuO. The production of ROS was negligible in the 
dark and enhanced under light irradiation [129]. ZnO and CuO were reported to be the most  
toxic nanoparticles.  
Recently, the ecotoxicity and cytotoxicity of several metal oxide nanoparticles were investigated 
using in vitro assays [130]. The proposed hazard ranking of the nanoparticles was CuO > ZnO >Sb2O3. 
The authors reported strong oxidative stress from the CuO nanoparticles [130]. Ko et al. [131] 
compared the toxic effects of different metal oxide nanoparticles on seed germination, gene mutation 
and bioluminescence activity of the Lactuca seed. The hazard ranking on seed germination was  
CuO > ZnO > Co3O4, Fe2O3, TiO2. Under bioluminescence, the ranking was ZnO > CuO > Co3O4 > 
Fe2O3 > TiO2 [131].  
5. Final Remarks 
The applications of metal oxide nanoparticles have recently increased. These nanoparticles have 
been considered for diverse applications in biotechnology, catalysis, environmental bioremediation, 
optics, electronics, and cell energy and in the medical and pharmaceutic sciences (as a drug delivery 
system in the treatment and diagnosis of several diseases) [132,133]. The traditional chemical and 
physical methods used to synthesize metal oxide nanoparticles are expensive, time- and energy-
consuming, tedious, toxic, and harmful to humans and the environment. The biogenic synthesis of 
metal oxide nanoparticles has emerged as an attractive alternative. Table 1 summarizes and compares 
the most important aspects of traditional versus green routes to synthesize metal oxide nanoparticles.  
The advantage and disadvantage of each route is highlighted, with the corresponding reference.  
Biogenic synthesis is straightforward and environmentally friendly [3−5,12−14]. Metal oxide 
nanoparticles can be obtained from different organisms such as plant extract, fungi, bacteria, algae, and  
actinomycetes [132]. This work reports the recent development in the use of green methods to obtain 
different types of metal oxide nanoparticles that can be used in a wide range of applications.  
As shown in Table 1, traditional methods of synthesis require both strong and weak chemical 
reducing agents, and protective agents (sodium borohydride, sodium citrate and alcohols), which are 
mostly toxic, flammable, cannot be easily disposed off due to environmental issues. Moreover, 
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traditional synthesis methods are carried out at elevated temperatures which generate a large amount of 
heat, and in some cases under inert atmosphere. Some traditional routes employed sophisticated 
instruments for experimentation. Although traditional methods yield nanoparticles with controlled size 
and dispersion (Table 1), these methods are considered not feasible. Hence, researchers are moving 
towards the biological synthesis for environmentally friendly synthesis of nanoparticles. As pointed 
out in Table 1, the main advantages of green methods to obtain the metal oxide nanoparticles are the 
simplicity, low cost, and no toxicity to the environment/humans. Moreover, different microflora such 
as bacteria, fungi, yeasts and plants have been successfully exploited as “nanofactories” for the 
synthesis of metal oxide nanoparticles. However, the main challenges related to green process to be 
overcome are: (i) limitations related to the scaling up the syntheses processes; (ii) the reproducibility of 
the biogenic processes needs to be improved; (iii) the mechanisms of nanoparticle formation are not 
completely elucidated; (iv) the control over nanoparticle size and distribution needs to be enhanced.  
To use metal oxide nanoparticles (either synthesized by traditional or green methods), it is 
necessary to investigate their potential toxicity. The effect of metal oxide nanoparticles on humans and 
the environment is a topic that has received increasing interest and debate [129–131]. The reviewed 
literature indicates that the potential toxicities of these nanomaterials have not been completely 
addressed. Most research focuses on the toxicity of chemical or physical synthesized metal oxide 
nanoparticles. There are few reports that characterize the nanotoxicity of biogenic metal oxide 
nanoparticles. Based on published papers, the clearly determination of the similarities and differences, 
in terms of toxicity, of metal oxide nanoparticle obtained by traditional methods and by biogenic 
routes can be considered complex. This complexity is due to the different routes of nanoparticles 
synthesis, their different size, presence or absence of capping molecules, diverse kinds of toxicity 
evaluation tests, and lack of deeper studies of nanotoxicity of biogenic nanoparticles. Therefore, the 
potential toxic effects of biogenically obtained nanoparticles should be investigated further. The key 
points that must be addressed include the following: (i) In terms of the nanotoxicity of metal oxide 
nanoparticles, is there a difference between nanoparticles synthesized by traditional and by biogenic 
methods? (ii) What is the uptake of these nanoparticles by both humans and the environment? (iii) What 
is the mechanism of nanoparticle toxicity? 
The literature suggests that nanotoxicity is related to (i) the possible release of (toxic) ions from 
metallic nanoparticles and (ii) the oxidative stress caused by the intrinsic characteristic of the 
nanoparticle (morphology, surface charge, size and chemical surface composition) [131]. Further 
studies are required to understand these mechanisms.  
Finally, the toxicity of nanoparticles can differ depending on the experimental method  
employed [131]. Nanoparticles themselves can interfere with many tests, and it is often necessary to 
adapt the protocol to obtain reliable results [134,135]. A standardization of toxicity protocols,  
long-term study of nanoparticle toxicity and the fate of these nanomaterials in human tissue and in the 
environment need to be further investigated. 
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Table 1. Comparison among main traditional versus green methods to synthesize metal oxide nanoparticles. 
 Traditional Methods of Synthesis    
Nanoparti Route Advantage Disadvantage Ref 
Bi2O3 
Hydrothermal process in assistance with the 
post-heat treatment route 
Control of temperature impacts resulting 
products 





Bi2O3 quantum dots in the interior of a 
nanogel of poly(vinyl alcohol) (PVA) 
The nanogels can adapt to a surrounding 
fluids physiological temperature 
Require inert atmosphere and 
irradiation with 60Co γ-ray source [69] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Bi2O3 
Plant pathogenic fungus—Fusarium 
oxysporum  
Room temperature, nanoparticles are 
stable in water 
Necessity to investigate the fungus 
proteins on the surface of Bi2O3  
[19] 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Co3O4 Solvothermal route Template-free approach High temperature [20] 
Co3O4 
Thermal decomposition of molecular 
precursors derived from salicylic acid and 
cobalt (II) acetate or chloride 
Template-free approach High temperature [21] 
Co3O4 
Nanoplates 
Solid-state crystal re-construction route by 
conversion of hexagonal β-Co(OH)2 
nanoplates 
Template-free approach Time consuming, high temperature [22] 
Co3O4 Thermal decomposition Control over size and shape 
Toxicity to human cells and DNA 
damage 
[70] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Co3O4 Marine bacterium Brevibacterium casei 
The protein coating on nanoparticles 
reduced agglomeration  
Challenges to be faced: better 
control over size and crystallinity  
[23] 
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Table 1. Cont. 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
CuO, Cu2O Thermal decomposition 
Control over nanoparticle size and 
distribution 
Costly in energy consumption [136] 
CuO Electrospinning Large scale production CuO Time consumption [137] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Cu2O Baker’s yeast Saccharomyces cerevisiae Room temperature no organic solvent 
Challenges to be faced: better 
control over size and scaling up 
[26] 
CuO, Cu2O Streptomyces sp. (Actinomycete biomass) Environmentally friendly approach 
Difficulties to obtain monodisperse 
nanoparticles and scaling up 
[27] 
CuO, Cu2O Escherichia coli at aerobic condition Neutral pH and room temperature 
Necessity to investigate the 




Penicillium aurantiogriseum, Penicillium 
citrinum and Penicillium waksmanii isolated 
from soil 
Environmentally friendly approach 
Low rate of synthesis, difficulties to 
obtain monodisperse nanoparticles. 
Microbial cultivation need to be 
improved 
[29] 
Cu2O Tridax procumbens leaf extract Simple, cost effective 
Challenges to be faced: better 
control over size and scaling up 
[30] 
CuO Aloe vera extract Simple, cost effective 
Challenges to be faced: better 
control over size and scaling up 
[31] 
CuO, Cu2O White-rot fungus Stereum hirsutum 
Simple method, under neutral or basic 
conditions 
Scaling up and fungus cultivation  [138] 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Fe3O4 Co-precipitation Relatively simple Polydispersity Fe3O4 [33] 
Fe3O4 
Thermal decomposition of iron (III) 
acetylacetonate (Fe(acac)3) 
Control of nanoparticle size and 
dispersibility 
High temperature and inert 
atmosphere 
[139] 
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Table 1. Cont. 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Fe3O4 Bacterium Actinobacter spp Aerobic conditions 




Mycelia of acidophillic fungi, Verticillium 
sp. and Fusarium oxysporum 
Extracellular synthesis 
Limited scaling up, fungi 
cultivation 
[35] 
Fe2O3, Fe3O4 Tannins from plants 
Natural, nontoxic, and biodegradable 
polyphenolic compounds 
Limited scaling up  [45] 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Sb2O3 γ-ray radiation-oxidation route Control over size and distribution Expensive, special equipment [140] 
Sb2O3 Hydrothermal synthesis Control over size and distribution 
External pressure,  
high temperatures 
[141] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Sb2O3 Baker’s yeast (S. cerevisiae) Low-cost, room temperature Presence of nanoparticle aggregates [48,49] 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
SiO2 
Micelle-templated protocol by varying the 
silica source (tetra alkoxysilane with 
different alkoxy group) and the type and 
amounts of co-surfactant alcohols  
Possibility to scaling up  
Relatively wide particle size 




Surfactant template method source of silica 
tetra alkoxysilanes, and by varying the 
amounts of co-surfactant alcohols 
Production of monodispersed spherical 
morphologies of nanoparticles 
Time and energy consuming [143] 
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Table 1. Cont. 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
SiO2 Fungus Fusarium oxysporum Facile room temperature 
Necessity to investigated the fungus 
secreted proteins involved in the 
synthesis  
[53] 
SiO2 Bacterium Actinobacter sp 
Particles were not cytotoxicity to human 
skin cells 
Relatively time consuming reaction [54] 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
TiO2 
Hydrothermal growth using diethylamine as 
a passivating agent 
Monodisperse nanoparticles with no phase 
transformation during the synthesis 
Time and energy consuming [144] 
TiO2 
Sol-gel method under different pH 
conditions 
Control over nanoparticle size 
Toxic solvents, time and energy 
consuming 
[145] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
TiO2 
Lactobacillus sp. (from yogurt and probiotic 
tablets) or Sachharomyces cerevisae 
(baker’s yeast) 
Simple, room temperature and cost 
effective  
Presence of few aggregates, 
difficult to scaling up  
[56,57] 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
UO2 
Radiolytic growth process in aqueous 
solutions through electron beam irradiation 
Control over size distribution Expensive, special equipment [146] 
UO2 
Hydrothermal synthesis method using 
hydrazine as a reducing agent 
Free of surfactant or template or organic 
amines 
Time and energy consuming [147] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
UO2 
Dissimilatory metal- and sulfate-reducing 
bacteria Desulfovibrio desulfuricans 
Simple, room temperature and cost 
effective 
Microorganism growth  [58–60] 
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Table 1. Cont. 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
ZnO 
Combustion process, in which 
Zn(CH3COO)2 precursors migrated with the 
aid of alcoholic fuel to the top of a burning 
lampwick and the chemical reactions 
occurred at the solvent-air interface of the 
ignited lampwick 
Relatively cost effective 
ZnO exhibited a nonuniform size 
and shape  
[148] 
ZnO Solvothermal synthesis ZnO with good monodispersion in water Organic toxic solvents  [149] 
ZnO 
Sol–gel processing technique based on 
hydrolysis of zinc acetate in methanol 
followed by supercritical drying in ethanol  
Control over size and shape Organic toxic solvents [150] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
ZnO Probiotic microbes Lactobacillus sporoge Mild conditions and low-cost Difficulties to scaling up [64] 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
ZrO2 Sol–gel method 
Nanoparticles with high chemical and 
structural homogeneity 
Thermal treatment [151] 
ZrO2 
Thermal decomposition of the Zr(IV) 
complex as in presence of methanol and 
monoethylene glycol  
Control over ZrO2 size and distribution 




Thermal decomposition by zirconium oleate 
complex in a high boiling organic solvent 
Production of oleophilic ZrO2 as 
nanofluilds  
Organic/toxic solvents, high 
temperatures 
[153] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
ZrO2 Fungus Fusarium oxysporum Extracellular hydrolysis, cost effect 




Metals 2015, 5 958 
 
 
Table 1. Cont. 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
SnO2 
Chemical precipitation using glycine which 
acts as a complexing agent and the 
surfactant sodium dodecyl sulfate as a 
stabilizing agent 
Control over SnO2 size 
Necessity to use surfactant and high 
temperature (up to 600 °C) 
[154] 
SnO2 
Solvothermal synthesis of SnO followed by 
its oxidation to SnO2  
Control over size and dispersion 




Reverse microemulsion method using 
different water to surfactant ratio 
The size of the SnO2 can be tcontrolled by 
variation of water-to-surfactant ratio 
Multiple steps, high temperature 
and necessity to sequential 
calcinations to remove the 
surfactant 
[156] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
SnO2 
Saraca indica flower extract as a reducing 
agent 
Simple, low cost Scaling up [67] 
 T Traditional Methods of Synthesis    
Nanoparti Route Advantage Disadvantage Ref 
Bi2O3 
Hydrothermal process in assistance with the 
post-heat treatment route 
Control of temperature impacts resulting 
products 





Bi2O3 quantum dots in the interior of a 
nanogel of poly(vinyl alcohol) (PVA) 
The nanogels can adapt to a surrounding 
fluids physiological temperature 
Require inert atmosphere and 
irradiation with 60Co γ-ray source [69] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Bi2O3 
Plant pathogenic fungus—Fusarium 
oxysporum  
Room temperature, nanoparticles are 
stable in water 
Necessity to investigate the fungus 
proteins on the surface of Bi2O3  
[19] 
  
Metals 2015, 5 959 
 
 
Table 1. Cont. 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Co3O4 Solvothermal route Template-free approach High temperature [20] 
Co3O4 
Thermal decomposition of molecular 
precursors derived from salicylic acid and 
cobalt (II) acetate or chloride 
Template-free approach High temperature [21] 
Co3O4 
Nanoplates 
Solid-state crystal re-construction route by 
conversion of hexagonal β-Co(OH)2 
nanoplates 
Template-free approach Time consuming, high temperature [22] 
Co3O4 Thermal decomposition Control over size and shape 
Toxicity to human cells and DNA 
damage 
[70] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Co3O4 Marine bacterium Brevibacterium casei 
The protein coating on nanoparticles 
reduced agglomeration  
Challenges to be faced: better 
control over size and crystallinity  
[23] 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
CuO, Cu2O Thermal decomposition 
Control over nanoparticle size and 
distribution 
Costly in energy consumption [136] 
CuO Electrospinning Large scale production CuO Time consumption [137] 
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Table 1. Cont. 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Cu2O Baker’s yeast Saccharomyces cerevisiae Room temperature no organic solvent 
Challenges to be faced: better 
control over size and scaling up 
[26] 
CuO, Cu2O Streptomyces sp. (Actinomycete biomass) Environmentally friendly approach 
Difficulties to obtain monodisperse 
nanoparticles and scaling up 
[27] 
CuO, Cu2O Escherichia coli at aerobic condition Neutral pH and room temperature 
Necessity to investigate the 




Penicillium aurantiogriseum, Penicillium 
citrinum and Penicillium waksmanii isolated 
from soil 
Environmentally friendly approach 
Low rate of synthesis, difficulties to 
obtain monodisperse nanoparticles. 
Microbial cultivation need to be 
improved 
[29] 
Cu2O Tridax procumbens leaf extract Simple, cost effective 
Challenges to be faced: better 
control over size and scaling up 
[30] 
CuO Aloe vera extract Simple, cost effective 
Challenges to be faced: better 
control over size and scaling up 
[31] 
CuO, Cu2O White-rot fungus Stereum hirsutum 
Simple method, under neutral or basic 
conditions 
Scaling up and fungus cultivation  [138] 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Fe3O4 Co-precipitation Relatively simple Polydispersity Fe3O4 [33] 
Fe3O4 
Thermal decomposition of iron (III) 
acetylacetonate (Fe(acac)3) 
Control of nanoparticle size and 
dispersibility 
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Table 1. Cont. 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Fe3O4 Bacterium Actinobacter spp. Aerobic conditions 




Mycelia of acidophillic fungi, Verticillium 
sp. and Fusarium oxysporum 
Extracellular synthesis 
Limited scaling up, fungi 
cultivation 
[35] 
Fe2O3, Fe3O4 Tannins from plants 
Natural, nontoxic, and biodegradable 
polyphenolic compounds 
Limited scaling up  [45] 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Sb2O3 γ-ray radiation-oxidation route Control over size and distribution Expensive, special equipment [140] 
Sb2O3 Hydrothermal synthesis Control over size and distribution 
External pressure,  
high temperatures 
[141] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
Sb2O3 Baker’s yeast (S. cerevisiae) Low-cost, room temperature Presence of nanoparticle aggregates [48,49] 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
SiO2 
Micelle-templated protocol by varying the 
silica source (tetra alkoxysilane with 
different alkoxy group) and the type and 
amounts of co-surfactant alcohols  
Possibility to scaling up  
Relatively wide particle size 




Surfactant template method source of silica 
tetra alkoxysilanes, and by varying the 
amounts of co-surfactant alcohols 
Production of monodispersed spherical 
morphologies of nanoparticles 
Time and energy consuming [143] 
  
Metals 2015, 5 962 
 
 
Table 1. Cont. 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
SiO2 Fungus Fusarium oxysporum Facile room temperature 
Necessity to investigated the fungus 
secreted proteins involved in the 
synthesis  
[53] 
SiO2 Bacterium Actinobacter sp. 
Particles were not cytotoxicity to human 
skin cells 
Relatively time consuming reaction [54] 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
TiO2 
Hydrothermal growth using diethylamine as 
a passivating agent 
Monodisperse nanoparticles with no phase 
transformation during the synthesis 
Time and energy consuming [144] 
TiO2 
Sol-gel method under different pH 
conditions 
Control over nanoparticle size 
Toxic solvents, time and energy 
consuming 
[145] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
TiO2 
Lactobacillus sp. (from yogurt and probiotic 
tablets) or Sachharomyces cerevisae 
(baker’s yeast) 
Simple, room temperature and cost 
effective  
Presence of few aggregates, 
difficult to scaling up  
[56,57] 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
UO2 
Radiolytic growth process in aqueous 
solutions through electron beam irradiation 
Control over size distribution Expensive, special equipment [146] 
UO2 
Hydrothermal synthesis method using 
hydrazine as a reducing agent 
Free of surfactant or template or organic 
amines 
Time and energy consuming [147] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
UO2 
Dissimilatory metal- and sulfate-reducing 
bacteria Desulfovibrio desulfuricans 
Simple, room temperature and cost 
effective 
Microorganism growth  [58–60] 
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Table 1. Cont. 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
ZnO 
Combustion process, in which 
Zn(CH3COO)2 precursors migrated with the 
aid of alcoholic fuel to the top of a burning 
lampwick and the chemical reactions 
occurred at the solvent-air interface of the 
ignited lampwick 
Relatively cost effective 
ZnO exhibited a nonuniform size 
and shape  
[148] 
ZnO Solvothermal synthesis ZnO with good monodispersion in water Organic toxic solvents  [149] 
ZnO 
Sol–gel processing technique based on 
hydrolysis of zinc acetate in methanol 
followed by supercritical drying in ethanol  
Control over size and shape Organic toxic solvents [150] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
ZnO Probiotic microbes Lactobacillus sporoge Mild conditions and low-cost Difficulties to scaling up [64] 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
ZrO2 Sol–gel method 
Nanoparticles with high chemical and 
structural homogeneity 
Thermal treatment [151] 
ZrO2 
Thermal decomposition of the Zr(IV) 
complex as in presence of methanol and 
monoethylene glycol  
Control over ZrO2 size and distribution 




Thermal decomposition by zirconium oleate 
complex in a high boiling organic solvent 
Production of oleophilic 
ZrO2 as nanofluilds  
Organic/toxic solvents, high 
temperatures 
[153] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
ZrO2 Fungus Fusarium oxysporum Extracellular hydrolysis, cost effect 
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Table 1. Cont. 
 Traditional Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
SnO2 
Chemical precipitation using glycine which 
acts as a complexing agent and the 
surfactant sodium dodecyl sulfate as a 
stabilizing agent 
Control over SnO2 size 
Necessity to use surfactant and high 
temperature (up to 600 °C) 
[154] 
SnO2 
Solvothermal synthesis of SnO followed by 
its oxidation to SnO2  
Control over size and dispersion 




Reverse microemulsion method using 
different water to surfactant ratio 
The size of the SnO2 can be controlled by 
variation of water-to-surfactant ratio 
Multiple steps, high temperature 
and necessity to sequential 
calcinations to remove the 
surfactant 
[156] 
 Green Methods of Synthesis    
Nanoparticle Route Advantage Disadvantage Ref 
SnO2 
Saraca indica flower extract as a reducing 
agent 
Simple, low cost Scaling up [67] 
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